**Introduction:** Morbihan's disease is classically defined as primarily Caucasian disease of chronic and recurrent erythema and edema of the middle and upper thirds of the face. It is believed to be a rare complication of rosacea. The disease is often difficult to diagnose until more severe signs are visible. Medical management is the primary mode of treatment; however, it is not curative nor very successful. When there is visual impairment, oculoplastic surgeons are consulted for surgical debulking.

**Case Presentation:** We present a 55 year old Navajo male who was referred from Indian Health Service Dermatology (IHSD) clinic to an oculoplastic surgeon in 2012 with a one year history of left upper lid (LUL) swelling. A LUL blepharoplasty was performed with improvement in vision. However, he returned a few years later with contralateral swelling. RUL blepharoplasty was performed and oral prednisone was started with modest improvement. He did not tolerate prednisone due to his diabetes so his treatment was stopped. The following year, he returned with bilateral eyelid swelling. He received subcutaneous triamcinolone eyelid injections yielding satisfactory results of decreased swelling. Despite this treatment, the edema returned after 6 months.

**Conclusion:** This is the first reported case of Morbihan's disease in the Navajo population. Two other Navajo patients have been diagnosed with Morbihan's disease at IHSD. Multidisciplinary approach with dermatology and oculoplastic surgery is required for complex medical and surgical management. Future work includes research into genetic predilection of Morbihan's in the Navajo population and targeted systemic treatment options.
